| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3389273 | A | Volume of distribution at steady state in rat at 1 mg/kg, iv | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 2. | ALA3389274 | A | Total clearance in rat at 1 mg/kg, iv | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 3. | ALA3389275 | A | Tmax in rat at 10 mg/kg, po | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 4. | ALA3389276 | A | Cmax in rat at 10 mg/kg, po | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 5. | ALA3389277 | A | AUC in rat at 10 mg/kg, po | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 6. | ALA3389278 | A | Oral bioavailability in rat at 10 mg/kg | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 7. | ALA3389279 | A | Oral bioavailability in rat assessed as 4-[2-({6-Fluoro-2-[({[3-(methyloxy)phenyl]methyl}amino)-carbonyl]-4-oxo-3,4-dihydroquinazolin-5-yl}oxy)ethyl]-benzoic acid at 3 mg/kg | Rattus norvegicus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 8. | ALA3389280 | A | Volume of distribution at steady state in guinea pig at 1 mg/kg, iv | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 9. | ALA3389281 | A | Total clearance in guinea pig at 1 mg/kg, iv | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 10. | ALA3389282 | A | Tmax in guinea pig at 3 mg/kg, po | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 11. | ALA3389283 | A | Cmax in guinea pig at 3 mg/kg, po | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 12. | ALA3389284 | A | AUC in guinea pig at 3 mg/kg, po | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 13. | ALA3389285 | A | Oral bioavailability in guinea pig at 3 mg/kg | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 14. | ALA3389286 | A | Oral bioavailability in guinea pig assessed as 4-[2-({6-Fluoro-2-[({[3-(methyloxy)phenyl]methyl}amino)-carbonyl]-4-oxo-3,4-dihydroquinazolin-5-yl}oxy)ethyl]-benzoic acid at 3 mg/kg | Cavia porcellus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 15. | ALA3389287 | A | Volume of distribution at steady state in rabbit at 1 mg/kg, iv | Oryctolagus cuniculus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 16. | ALA3389288 | A | Total clearance in rabbit at 1 mg/kg, iv | Oryctolagus cuniculus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 17. | ALA3389289 | A | Tmax in rabbit at 10 mg/kg, po | Oryctolagus cuniculus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 18. | ALA3389290 | A | Cmax in rabbit at 10 mg/kg, po | Oryctolagus cuniculus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 19. | ALA3389291 | A | AUC in rabbit at 10 mg/kg, po | Oryctolagus cuniculus | 1 | ALA3352689 | organism-based format | Scientific Literature | |
| 20. | ALA3389292 | A | Oral bioavailability in rabbit at 10 mg/kg | Oryctolagus cuniculus | 1 | ALA3352689 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!